Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies
Non-alcoholic fatty liver disease (NAFLD) is frequently associated with metabolic disorders, being highly prevalent in obese and diabetic patients. Many concomitant factors that promote systemic and liver inflammation are involved in NAFLD pathogenesis, with a growing body of evidence highlighting t...
Main Authors: | Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2023.1110536/full |
Similar Items
-
Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease
by: Lucia Giuli, et al.
Published: (2023-06-01) -
Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis
by: Valeria Maccauro, et al.
Published: (2023-04-01) -
Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma
by: Francesca Romana Ponziani, et al.
Published: (2019-05-01) -
Low Short-Chain-Fatty-Acid-Producing Activity of the Gut Microbiota Is Associated with Hypercholesterolemia and Liver Fibrosis in Patients with Metabolic-Associated (Non-Alcoholic) Fatty Liver Disease
by: Xinlu Cao, et al.
Published: (2023-10-01) -
Influence of Gut–Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic Management
by: Francesco Santopaolo, et al.
Published: (2022-08-01)